The glioma risk allele rs1063192-C was highly correlated with increased ANRIL expression (P = 10−61), while the melanoma risk variant rs1011970-T correlated with reduced expression of ANRIL. Neither was associated with CDKN2A or CDKN2B expression. This evidence concerns the gene CDKN2A and central nervous system cancer.